Prognosis of patients with breast cancer: Causes of death and effects of time since diagnosis, age, and tumor characteristics

Journal of Clinical Oncology

Volumn 29, Issue 30, 2011, Pages 4014-4021

  Colzani, Edoardo ^a,c   Liljegren, Annelie ^a,b   Johansson, Anna L V ^a   Adolfsson, Jan ^a   Hellborg, Henrik ^a   Hall, Per F L ^a   Czene, Kamila ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CAUSE OF DEATH; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SWEDEN;

EID: 80054766181     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.6462     Document Type: Article

References (38)

1. Early Breast Cancer Trial Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
2. Imkampe AK, Bates T: Improvements in breast cancer survival over time, related to adjuvant treatment and node status. Eur J Surg Oncol 35: 151-155, 2009
3. Kalager M, Haldorsen T, Bretthauer M, et al.: Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: A population-based cohort study. Breast Cancer Res 11:R44, 2009
4. Overgaard M, Jensen MB, Overgaard J, et al.: Postoperative radiotherapy in high-risk post-menopausal breast-cancer patients given adjuvanttamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353:1641-1648, 1999 (Pubitemid 29224519)
5. Sarkeala T, Heinävaara S, Anttila A: Organised mammography screening reduces breast cancer mortality: A cohort study from Finland. Int J Cancer 122:614-619, 2008 (Pubitemid 350308954)
6. Levi F, Bosetti C, Lucchini F, et al.: Monitoring the decrease in breast cancer mortality in Europe. Eur J Cancer Prev 14:497-502, 2005 (Pubitemid 41689648)
7. Louwman WJ, Klokman WJ, Coebergh JW: Excess mortality from breast cancer 20 years after diagnosis when life expectancy is normal. Br J Cancer 84:700-703, 2001 (Pubitemid 32239007)
8. Du XL, Fox EE, Lai D: Competing causes of death for women with breast cancer and change over time from 1975 to 2003. Am J Clin Oncol 31:105-116, 2008 (Pubitemid 351519161)
9. Schairer C, Mink PJ, Carroll L, et al.: Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst, 96:1311-1321, 2004 (Pubitemid 39264120)
10. Dabakuyo TS, Bonnetain F, Roignot P, et al.: Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival. Ann Oncol 19:276-283, 2008 (Pubitemid 351201708)
11. Swanson GM, Lin CS: Survival patterns among younger women with breast cancer: The effects of age, race, stage, and treatment. J Natl Cancer Inst Monogr 16:69-77, 1994
12. Adami HO, Malker B, Holmberg L, et al.: The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315:559-563, 1986 (Pubitemid 16052469)
13. de la Rochefordiere A, Asselain B, Campana F, et al.: Age as prognostic factor in premenopausal breast carcinoma. Lancet 341:1039-1043, 1993 (Pubitemid 23114394)
14. Fredholm H, Eaker S, Frisell J, et al.: Breast cancer in young women: Poor survival despite intensive treatment. PLoS One 4:e7695, 2009
15. Lambert PC, Royston P: Further developments of flexible parametric models for survival analysis. Stata J 9:265-290, 2009
16. Royston P, Parmar MK: Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 21:2175-2197, 2002 (Pubitemid 34830755)
17. Gnerlich JL, Deshpande AD, Jeffe DB, et al.: Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg 208:341-347, 2009
18. Maggard MA, O'Connell JB, Liu JH, et al.: Do young breast cancer patients have worse outcomes? J Surg Res 113:109-113, 2003 (Pubitemid 36999799)
19. Bharat A, Aft RL, Gao F, et al.: Patient and tumor characteristics associated with increased mortality in young women (≤ 40 years) with breast cancer. J Surg Oncol 100:248-251, 2009
20. El Saghir NS, Seoud M, Khalil MK, et al.: Effects of young age at presentation on survival in breast cancer. BMC Cancer 6:194, 2006
21. Gajdos C, Tartter PI, Bleiweiss IJ, et al.: Stage 0 to stage III breast cancer in young women. J Am Coll Surg 190:523-529, 2000 (Pubitemid 30230699)
22. Klauber-Demore N: A Comprehensive Review of Breast Cancer in Young Women. Breast Dis 23:1-2, 2009
23. Grann VR, Troxel AB, Zojwalla NJ, et al.: Hormone receptor status and survival in a population-basedcohort of patients with breast carcinoma. Cancer 103:2241-2251, 2005 (Pubitemid 40686567)
24. Dunnwald LK, Rossing MA, Li CI: Hormone receptor status, tumor characteristics, and prognosis: A prospective cohort of breast cancer patients. Breast Cancer Res 9:R6, 2007
25. Dignam JJ, Dukic V, Anderson SJ, et al.: Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer. Breast Cancer Res Treat 116:595-602, 2009
26. Warwick J, Tabàr L, Vitak B, et al.: Time-dependent effects on survival in breast carcinoma: Results of 20 years of follow-up from the Swedish Two-County Study. Cancer 100:1331-1336, 2004
27. Michaelson JS, Chen LL, Silverstein MJ, et al.: How cancer at the primary site and in the lymph nodes contributes to the risk of cancer death. Cancer 115:5095-5107, 2009
28. Andersson Y, Frisell J, Sylvan M, et al.: Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol 28: 2868-2873, 2010
29. de Boer M, van Deurzen CH, van Dijck JA, et al.: Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361:653-663, 2009
30. Leidenius MH, Vironen JH, Heikkilä PS, et al.: Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer. Ann Surg Oncol 17:254-262, 2010
31. Fang F, Keating NL, Mucci LA, et al.: Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: Cohort study in the United States. J Natl Cancer Inst 102:307-314, 2010
32. Chiu SY, Duffy S, Yen AM, et al.: Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev 19:1219-1228, 2010
33. Chamberlain J, Coleman D, Ellman R, et al.: Verification of the cause of death in the trial of early detection of breast cancer. Br J Cancer 64:1151-1156, 1991
34. Nyström L, Larsson LG, Rutqvist LE, et al.: Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. Acta Oncol 34:145-152, 1995
35. Johansson LA, Westerling R: Comparing Swedish hospital discharge records with death certificates: Implications for mortality statistics. Int J Epidemiol 29:495-502, 2000 (Pubitemid 30447254)
36. Goldoni CA, Bonora K, Ciatto S, et al.: Misclassification of breast cancer as cause of death in a service screening area. Cancer Causes Control 20: 533-538, 2009
37. Hilsenbeck SG, Ravdin PM, de Moor CA, et al.: Time-dependence of hazard ratios for prognostic factors in primary breast cancer. Breast Cancer Res Treat 52:227-237, 1998 (Pubitemid 29056098)
38. Goldhirsch A, Glick JH, Gelber RD, et al.: Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Clin Oncol 19:3817-3827, 2001 (Pubitemid 32880060)